1. Medtech Insight
  2. >>Policy & Regulation
  3. >>Legislation

Device User-Fee Agreement Gets A Senate Hearing

 
• By Sue Darcey

US FDA user-fee reauthorization agreements, including the medical device MDUFA IV package, will be dissected at a Senate Health, Education, Labor, and Pensions (HELP) Committee hearing on March 21.

The device user-fee reauthorization agreement inked by US FDA and industry groups last summer will finally get a public hearing in Congress: March 21 in the Senate Help, Education, Labor and Pensions Committee.

In addition to devices, the hearing will address user-fee agreements for drugs and biologics. FDA's current user-fee programs are scheduled...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Medtech Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Legislation

More from Policy & Regulation

‘Small Business’ Applications For Waiver Of Device User Fees To Be Streamlined By US FDA

 
• By Brian Bossetta

FDA moves forward with implementing previous draft guidance and will consolidate forms, but the agency estimates limited impact in the total reporting burden.

FDA Outlines Responsibilities For Owners Of Transferred 510(k)s

 
• By Elizabeth Orr

The US FDA's new draft guidance details the responsibilities of new owners of 510(k) clearances, including making timely updates device listings in FURLS and GUDID to maintain accurate information for safety alerts and recalls. Comments on the draft are accepted until 4 August.

US House Budget Sets FDA FY26 Funding At $3.2B

 
• By Sue Sutter and Derrick Gingery

A US House bill would give the FDA $33.1m more in budget authority than requested by the Trump Administration for fiscal year 2026. The measure was sent to the full House Appropriations committee on a party-line vote.